2025-09-02 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,974,585 |
2,374,085 |
|
|
|
2025-08-12 |
13G/A
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
5,697,605 |
8,800,000 |
|
|
|
2025-08-12 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
|
1,350,000 |
|
|
|
2025-08-12 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
5,750,000 |
6,800,000 |
|
|
|
2025-08-12 |
13G
|
ADGM / Adagio Medical Holdings, Inc.
|
|
|
821,261 |
|
|
|
2025-08-12 |
13G
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
14,614,449 |
|
|
|
2025-08-12 |
13G
|
TNGX / Tango Therapeutics, Inc.
|
|
|
5,905,349 |
|
|
|
2025-08-12 |
13G/A
|
IMUX / Immunic, Inc.
|
|
1,398,600 |
10,479,337 |
|
|
|
2025-08-12 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
3,061,750 |
2,525,000 |
|
|
|
2025-08-12 |
13G/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
4,392,696 |
3,575,964 |
|
|
|
2025-08-12 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
3,634,475 |
9,002,580 |
|
|
|
2025-08-12 |
13G/A
|
SDRL / Seadrill Limited
|
|
4,200,535 |
3,138,286 |
|
|
|
2025-08-12 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
12,516,500 |
15,016,500 |
|
|
|
2025-08-12 |
13G/A
|
ENSC / Ensysce Biosciences, Inc.
|
|
74,711 |
74,711 |
|
|
|
2025-08-12 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
8,102,098 |
6,601,938 |
|
|
|
2025-08-12 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,742,758 |
1,974,585 |
|
|
|
2025-08-12 |
13G/A
|
ZEO / Zeo Energy Corp.
|
|
760,000 |
760,000 |
|
|
|
2025-08-12 |
13G/A
|
INZY / Inozyme Pharma, Inc.
|
|
|
0 |
|
|
|
2025-08-12 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
990,000 |
1,100,000 |
|
|
|
2025-08-12 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
3,000,000 |
4,589,000 |
|
|
|
2025-08-12 |
13G/A
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
6,954,000 |
8,403,000 |
|
|
|
2025-08-12 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
325,000 |
210,000 |
|
|
|
2025-06-20 |
13D/A
|
|
|
|
50,912 |
|
|
|
2025-05-12 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
9,602,280 |
8,102,098 |
|
|
|
2025-05-12 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
9,627,304 |
8,201,344 |
|
|
|
2025-05-12 |
13G/A
|
SDRL / Seadrill Limited
|
|
3,429,169 |
4,200,535 |
|
|
|
2025-05-12 |
13G/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
3,322,146 |
4,392,696 |
|
|
|
2025-05-12 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
9,703,351 |
12,516,500 |
|
|
|
2025-05-12 |
13G
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
5,697,605 |
|
|
|
2025-05-12 |
13G
|
PRAX / Praxis Precision Medicines, Inc.
|
|
854,083 |
1,742,758 |
|
|
|
2025-05-12 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
990,000 |
|
|
|
2025-05-12 |
13G
|
SLDB / Solid Biosciences Inc.
|
|
1,754,159 |
6,729,484 |
|
|
|
2025-05-12 |
13G
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
6,954,000 |
|
|
|
2025-05-12 |
13G
|
ENSC / Ensysce Biosciences, Inc.
|
|
|
74,711 |
|
|
|
2025-05-12 |
13G/A
|
AEVA / Aeva Technologies, Inc.
|
|
|
1,401,454 |
|
|
|
2025-05-12 |
13G
|
TRAW / Traws Pharma, Inc.
|
|
|
330,000 |
|
|
|
2025-05-12 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
2,928,086 |
1,277,000 |
|
|
|
2025-05-12 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
8,503,780 |
|
|
|
2025-05-12 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
2,250,000 |
0 |
|
|
|
2025-05-12 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
4,210,429 |
4,411,572 |
|
|
|
2025-05-12 |
13G/A
|
LXEO / Lexeo Therapeutics, Inc.
|
|
2,209,615 |
237,953 |
|
|
|
2025-02-12 |
13G
|
PRQR / ProQR Therapeutics N.V.
|
|
|
9,602,280 |
|
|
|
2025-02-12 |
13G
|
MNPR / Monopar Therapeutics Inc.
|
|
|
599,195 |
|
|
|
2025-02-12 |
13G/A
|
IMUX / Immunic, Inc.
|
|
5,594,406 |
1,398,600 |
|
|
|
2025-02-12 |
13G
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
6,551,055 |
|
|
|
2025-02-12 |
13G/A
|
ENGN / enGene Holdings Inc.
|
|
2,329,768 |
1,528,768 |
|
|
|
2025-02-12 |
13G/A
|
LXEO / Lexeo Therapeutics, Inc.
|
|
2,597,736 |
2,209,615 |
|
|
|
2025-02-12 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
3,791,420 |
5,750,000 |
|
|
|
2025-02-12 |
13G
|
DYNX / Dynamix Corporation
|
|
|
1,350,000 |
|
|
|
2025-02-12 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
3,735,741 |
2,928,086 |
|
|
|
2025-02-12 |
13G
|
ZVRA / Zevra Therapeutics, Inc.
|
|
|
3,650,000 |
|
|
|
2025-02-12 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
218,813 |
325,000 |
|
|
|
2025-02-12 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
9,627,304 |
|
|
|
2025-02-12 |
13G
|
SDRL / Seadrill Limited
|
|
|
3,429,169 |
|
|
|
2025-02-12 |
13G
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
3,000,000 |
|
|
|
2025-02-12 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
|
2,250,000 |
|
|
|
2025-02-12 |
13G
|
JANX / Janux Therapeutics, Inc.
|
|
|
3,061,750 |
|
|
|
2025-02-12 |
13G
|
STR / Sitio Royalties Corp.
|
|
|
6,263,396 |
|
|
|
2024-11-19 |
13G
|
ZEO / Zeo Energy Corp.
|
|
|
760,000 |
|
|
|
2024-11-12 |
13G/A
|
MGTX / MeiraGTx Holdings plc
|
|
|
5,229,099 |
|
|
|
2024-11-12 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
|
3,634,475 |
|
|
|
2024-11-12 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
|
2,842,163 |
|
|
|
2024-11-12 |
13G/A
|
GHLD / Guild Holdings Company
|
|
|
597,110 |
|
|
|
2024-11-12 |
13G/A
|
AMAL / Amalgamated Financial Corp.
|
|
|
716,262 |
|
|
|
2024-11-12 |
13G/A
|
PWP / Perella Weinberg Partners
|
|
|
1,037,615 |
|
|
|
2024-11-12 |
13G/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
|
2,000,594 |
|
|
|
2024-11-12 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
528,937 |
|
|
|
2024-11-12 |
13G/A
|
SVRA / Savara Inc.
|
|
|
6,753,701 |
|
|
|
2024-11-12 |
13G/A
|
ANNX / Annexon, Inc.
|
|
|
3,485,931 |
|
|
|
2024-11-12 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
|
1,754,159 |
|
|
|
2024-11-12 |
13G
|
HRTX / Heron Therapeutics, Inc.
|
|
|
8,850,000 |
|
|
|
2024-11-12 |
13G/A
|
AURA / Aura Biosciences, Inc.
|
|
|
4,881,125 |
|
|
|
2024-11-12 |
13G/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
3,322,146 |
|
|
|
2024-11-12 |
13G/A
|
VINP / Vinci Compass Investments Ltd.
|
|
|
0 |
|
|
|
2024-11-12 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
5,156,299 |
3,791,420 |
|
|
|
2024-11-12 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
|
9,703,351 |
|
|
|
2024-11-12 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
|
2,250,132 |
|
|
|
2024-11-12 |
13G/A
|
VERU / Veru Inc.
|
|
|
7,861,111 |
|
|
|
2024-11-12 |
13G/A
|
NKTX / Nkarta, Inc.
|
|
|
3,600,000 |
|
|
|
2024-11-12 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
854,083 |
|
|
|
2024-11-12 |
13G/A
|
VSTM / Verastem, Inc.
|
|
|
0 |
|
|
|
2024-11-12 |
13G
|
ENGN / enGene Holdings Inc.
|
|
|
2,329,768 |
|
|
|
2024-11-12 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
3,735,741 |
|
|
|
2024-11-12 |
13G
|
LXEO / Lexeo Therapeutics, Inc.
|
|
|
2,597,736 |
|
|
|
2024-11-12 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
1,419,792 |
|
|
|
2024-11-12 |
13G
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
218,813 |
|
|
|
2024-11-12 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
0 |
|
|
|
2024-11-12 |
13G
|
IMUX / Immunic, Inc.
|
|
|
5,594,406 |
|
|
|
2024-11-12 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
369,097 |
|
|
|
2024-11-04 |
13D
|
GLYC / GlycoMimetics, Inc.
|
|
|
5,091,231 |
|
|
|
2024-10-22 |
13D/A
|
ORKA / Oruka Therapeutics, Inc.
|
|
|
175,000 |
|
|
|
2024-06-03 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
|
4,210,429 |
|
|
|
2024-05-01 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
5,156,299 |
5,156,299 |
|
|
|
2024-04-30 |
13G
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
5,156,299 |
|
|
|
2024-04-05 |
13D
|
ABIO / ARCA biopharma, Inc.
|
|
|
1,200,000 |
|
|
|